n-methyl-3,4-methylenedioxyamphetamine has been researched along with Long Sleeper Syndrome in 10 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The dependent variable was the number of reported ecstasy-related adverse effects." | 1.37 | Modelling the adverse effects associated with ecstasy use. ( Fisk, JE; Hadjiefthyvoulou, F; Montgomery, C; Murphy, PN, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ogeil, RP | 3 |
| Rajaratnam, SM | 3 |
| Broadbear, JH | 3 |
| Tait, RJ | 1 |
| George, A | 1 |
| Olesen, S | 1 |
| Taurah, L | 1 |
| Chandler, C | 1 |
| Sanders, G | 1 |
| Carhart-Harris, RL | 1 |
| Nutt, DJ | 1 |
| Munafò, M | 1 |
| Wilson, SJ | 1 |
| Fisk, JE | 1 |
| Murphy, PN | 1 |
| Montgomery, C | 1 |
| Hadjiefthyvoulou, F | 1 |
| Phillips, JG | 1 |
| Redman, JR | 1 |
| Soar, K | 1 |
| Parrott, AC | 1 |
| Fox, HC | 1 |
| Rendell, PG | 1 |
| Gray, TJ | 1 |
| Henry, JD | 1 |
| Tolan, A | 1 |
| Allen, RP | 1 |
| McCann, UD | 1 |
| Ricaurte, GA | 1 |
1 trial available for n-methyl-3,4-methylenedioxyamphetamine and Long Sleeper Syndrome
| Article | Year |
|---|---|
Prospective memory impairment in "ecstasy" (MDMA) users.
Topics: Adult; Analysis of Variance; Female; Humans; Male; Marijuana Abuse; Memory Disorders; N-Methyl-3,4-m | 2007 |
9 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Long Sleeper Syndrome
| Article | Year |
|---|---|
Male and female ecstasy users: differences in patterns of use, sleep quality and mental health outcomes.
Topics: Adult; Affect; Amphetamine-Related Disorders; Female; Guilt; Hallucinogens; Humans; Male; Mental Hea | 2013 |
'Ecstasy' and the use of sleep medications in a general community sample: a 4-year follow-up.
Topics: Adult; Amphetamine-Related Disorders; Australian Capital Territory; Female; Follow-Up Studies; Hallu | 2013 |
Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
Topics: Adolescent; Adult; Alcohol-Related Disorders; Amphetamine-Related Disorders; Attitude to Health; Dep | 2014 |
Current and former ecstasy users report different sleep to matched controls: a web-based questionnaire study.
Topics: Adolescent; Adult; Female; Hallucinogens; Humans; Illicit Drugs; Internet; Male; Middle Aged; N-Meth | 2009 |
Modelling the adverse effects associated with ecstasy use.
Topics: Affect; Alcohol Drinking; Anxiety; Binomial Distribution; Confusion; Dose-Response Relationship, Dru | 2011 |
Ecstasy use and self-reported disturbances in sleep.
Topics: Adolescent; Adult; Age Factors; Female; Hallucinogens; Humans; Male; Middle Aged; N-Methyl-3,4-methy | 2011 |
Disturbed sleep in ecstasy users reported by partners/roommates.
Topics: Adrenergic Uptake Inhibitors; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Sleep Wake Disorders | 2012 |
Persistent neuropsychological problems after 7 years of abstinence from recreational Ecstasy (MDMA): a case study.
Topics: Adrenergic Uptake Inhibitors; Adult; Depressive Disorder; Erectile Dysfunction; Follow-Up Studies; H | 2004 |
Persistent effects of (+/- )3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on human sleep.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Amphetamines; Electroencephalography; Female; Humans; Male; Me | 1993 |